UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007525
Receipt number R000008887
Scientific Title Randomized phase III trial of adjuvant chemo-immunotherapy with dendritic cells and activated killer cells in patients with resected primary lung cancer patients
Date of disclosure of the study information 2012/04/01
Last modified on 2015/04/22 07:54:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized phase III trial of adjuvant chemo-immunotherapy with dendritic cells and activated killer cells in patients with resected primary lung cancer patients

Acronym

Immunotherapy for post-surgical lung cancer patients

Scientific Title

Randomized phase III trial of adjuvant chemo-immunotherapy with dendritic cells and activated killer cells in patients with resected primary lung cancer patients

Scientific Title:Acronym

Immunotherapy for post-surgical lung cancer patients

Region

Japan


Condition

Condition

Primary lung cancer

Classification by specialty

Pneumology Chest surgery Adult

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To compare the survival and recurrence free survival in the phase III study of post surgical lung cancer patients. group A: patients who received postsurgical immunotherapy and chemotherapy with activated killer cells and dendritic cells . Group B: patients who received chemotherapy alone.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase III


Assessment

Primary outcomes

2 year survival,5 year survival

Key secondary outcomes

recurrence free survival, safety,
seide effect


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

group A: immunotherapy and chemotherapy
chemotherapy: CBDCA+GEM orCBDCA+PTX or CBDCA+PEM 4 courses every month
2 courses of Induction chemotherapy are applied for advanced cases Immunotherapy: every month for 6 courses and every 2 months for 2 years thereafter

Interventions/Control_2

group B chemotherapy
chemotherapy: CBDCA+GEM orCBDCA+PTX or CBDCA+PEM 4 courses every month
2-3 courses of Induction chemotherapy are applied for advanced cases

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

1)surgically resected primary non-small cell lung cancer patients
2) stage IIA -IV with no residual cancer after surgery
3) PS=0 or 1
4)more than 3X109(3 billion) activated killer cells are available from regional lymoh nodes for one course of immunotherapy
5) postsurgial treatment can be started within 2 months after surgery
6)chief organ functions are preserved
12000mm3 > WBC> 3000/mm3
Plt >100,000/mm3
Hb> 8.0g/dl TBil<2mg/dl
AST,ALT <100IU/L
Creatinin <1.2mg/dl
9)written informed consent are obtained

Key exclusion criteria

1 with other active cancer
2 with viral infection (HIV,HBS,HCV)
3 small cell lung cancer( combied SCLC are included for the study)

Target sample size

160


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hideki Kimura M.D.

Organization

Chiba Cancer Center

Division name

Division of thoaracic diseases

Zip code


Address

666-2 Nitona-cho, Chu-O-ku ,Chiba city Chiba

TEL

043-264-5431

Email

h.kimura@chiba-saiseikai.com


Public contact

Name of contact person

1st name
Middle name
Last name Hideki Kimura M.D.

Organization

Chiba Cancer Center

Division name

DIvision of Thoracic Diseases

Zip code


Address

666-2 Nitona-cho, Chu-o-ku ,Chiba City,Chiba

TEL

043-264-5431

Homepage URL


Email

hkimura@chiba-cc.jp


Sponsor or person

Institute

Chiba Cancer Center

Institute

Department

Personal name



Funding Source

Organization

Chiba Cancer Center

Organization

Division

Category of Funding Organization

Local Government

Nationality of Funding Organization

None


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2007 Year 04 Month 01 Day

Date of IRB


Anticipated trial start date

2007 Year 04 Month 01 Day

Last follow-up date

2013 Year 03 Month 01 Day

Date of closure to data entry

2013 Year 03 Month 01 Day

Date trial data considered complete

2013 Year 03 Month 01 Day

Date analysis concluded

2013 Year 04 Month 01 Day


Other

Other related information



Management information

Registered date

2012 Year 03 Month 18 Day

Last modified on

2015 Year 04 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008887


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name